Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in burns care

Annals of Clinical Microbiology and Antimicrobials

Volumn 10, Issue , 2011, Pages

  Aujoulat, Fabien ^a   Lebreton, Françoise ^b   Romano, Sara ^a,c   Delage, Milena ^a   Marchandin, Hélène ^a,d   Brabet, Monique ^b   Bricard, Françoise ^c   Godreuil, Sylvain ^d   Parer, Sylvie ^c   Jumas Bilak, Estelle ^a,c  

^a UNIV MONTPELLIER   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c Montpellier 1 University   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Antiseptics; Burns; Diffusion assay; ERIC PCR; Pseudomonas aeruginosa; Silver sulphadiazine

Indexed keywords

AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORHEXIDINE; CIPROFLOXACIN; CLAVULANIC ACID; FLAMMACERIUM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MAFENIDE; NALIDIXIC ACID; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POVIDONE IODINE; SULFADIAZINE SILVER; TICARCILLIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURN; BURN UNIT; CLINICAL ARTICLE; COMPARATIVE STUDY; DISK DIFFUSION; DRUG EFFICACY; ENTEROBACTERIAL REPETITIVE INTERGENIC CONSENSUS; HUMAN; MOLECULAR TYPING; NONHUMAN; PATIENT CARE; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BURNS; CROSS INFECTION; DISK DIFFUSION ANTIMICROBIAL TESTS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 79959433474     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-10-27     Document Type: Article

References (30)

1. Allgower M, Schoenberger GA, Sparkes BG. Pernicious effectors in burns. Burns 2007, 34S1:S1-S55.
2. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev 2006, 19:403-434. 10.1128/CMR.19.2.403-434.2006, 1471990, 16614255.
3. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unity: experience of seven years. J Hospit Infect 2003, 53:6-13.
4. Kolmos HJ, Thuensen B, Nielsen SV, Lohmann M, Kristoffersen K, Rosdahl VT. Outbreak of infection in a burns unit due to Pseudomonas aeruginosa originating from contaminated tubing used for irrigation of patients. J Hospit Infect 1993, 24:11-21.
5. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis 2003, 37:543-550. 10.1086/376993, 12905139.
6. Ferreira AC, Gobara S, Costa SE, Sauaia N, Mamizuka EM, van der Heijden IM, Soares RE, Almeida GD, Fontana C, Levin AS. Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients. Infect Control Hosp Epidemiol 2004, 25:868-872. 10.1086/502311, 15518031.
7. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother 2005, 49:3538-3540. 10.1128/AAC.49.8.3538-3540.2005, 1196250, 16048978.
8. Garner JP, Heppell PSJ. Cerium nitrate in the management of burns. Burns 2005, 31:539-547. 10.1016/j.burns.2005.01.014, 15955636.
9. Ross D, Phipps A, Clarke J. The use of nitrate-silver sulphadiazine as a topical burns dressing. British J Plastic Surg 1993, 46:582-584.
10. Vehmeyer-Heeman M, Tondu T, Vanden Kerckhove E, Boeckx JW. Application of cerium nitrate-silver sulphadiazine allows for postponement of excision and grafting. Burns 2006, 32:60-63. 10.1016/j.burns.2005.06.022, 16380214.
11. Vehmeyer-Heeman M, Van Holder C, Nieman F, Vanden Kerckhove E, Boeckx JW. Predictors of mortality: a comparison between two burn wounds treatment policies. Burns 2007, 33:167-172. 10.1016/j.burns.2006.07.014, 17240072.
12. Pirnay JP, De Vos D, Cochez C, Bilocq F, Pirson J, Struelens M, Duinslaeger L, Cornelis P, Zizi M, Vanderkelen A. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistance of a multidrug-resistant clone and silver sulfadiazine-resistant clone. J Clin Microbiol 2003, 41:1192-1202. 10.1128/JCM.41.3.1192-1202.2003, 150314, 12624051.
13. Corne P, Godreuil S, Jean-Pierre H, Campos J, Jumas-Bilak E, Parer S, Marchandin H. Unusual implication of biopsy forceps in outbreaks of Pseudomonas aeruginosa infections and pseudo-infections related to bronchoscopy. J Hosp Infect 2005, 61:20-26. 10.1016/j.jhin.2005.01.024, 16019111.
14. Mercier E, Jumas-Bilak E, Allardet-Servent A, O'Callaghan D, Ramuz M. Polymorphism in Brucella strains detected by studying distribution of two short repetitive DNA elements. J Clin Microbiol 1996, 34:1299-1302. 229004, 8727925.
15. Courvalin P, Leclerc R, Bingen E. Antibiogramme. 2006, ESKA, France.
16. Nathan P, Law EJ, Murphy DF, MacMillan BG. A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds. Burns 1978, 4:177-187.
17. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 2004, 42:5644-5649. 10.1128/JCM.42.12.5644-5649.2004, 535286, 15583294.
18. Morales G, Wiehlmann L, Gudowius P, Morales G, Wiehlmann L, Gudowius P, van Delden C, Tümmler B, Martinez JL, Rojo F. Structure of Pseudomonas aeruginosa population analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J Bacteriol 2004, 186:4228-4237. 10.1128/JB.186.13.4228-4237.2004, 421620, 15205425.
19. Onteniente L, Brisse S, Tassios PT, Vergnaud G. Evaluation of the polymorphisms associated with tandem repeats for Pseudomonas aeruginosa strain typing. J Clin Microbiol 2003, 41:4991-4997. 10.1128/JCM.41.11.4991-4997.2003, 262500, 14605129.
20. Johnson KF, Arduino SM, Stine OC, Johnson JA, Harris AD. Multilocus sequence typing compared to Pulsed-Field Gel Electrophoresis for molecular typing of Pseudomonas aeruginosa. J Clin Microbiol 2007, 45:3707-3712. 10.1128/JCM.00560-07, 2168506, 17881548.
21. Syrmis MW, O'Carroll MR, Sloots TP, Coulter C, Wainwright CE, Bell SC, Nissen MD. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element based PCR assays. J Med Microbiol 2004, 53:1089-1096. 10.1099/jmm.0.45611-0, 15496385.
22. Shannon KP, French GL. Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000. J Antimicrobial Chemother 2004, 53:818-825.
23. Hsueh PR, Teng LJ, Yang PC, Chen YC, Ho SW, Luh KT. Persistance of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol 1998, 36:1347-1351. 104826, 9574703.
24. Neely AN, Gardner J, Durkee P, Greenhalgh DG, Gallagher JJ, Herdon DN, Tompkins RG, Kagan RJ. Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?. J Burn Care Res 2009, 30:19-29. 10.1097/BCR.0b013e3181921eed, 19060725.
25. Oliver A, Levin BR, Juan C, Baquero F, Blazquez J. Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections. Antimicrob Agents Chemother 2004, 48:4226-4233. 10.1128/AAC.48.11.4226-4233.2004, 525420, 15504845.
26. Wasserman D, Schlotterer M, Lebreton F, Levy J, Guelfi MC. Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. Burns 1989, 15:257-260. 10.1016/0305-4179(89)90045-4, 2765148.
27. Marone P, Monzillo V, Perversi L, Carretto E. Comparative in vitro activity of silver sulfadiazine alone and in combination with cerium nitrate against staphylococci and gram-negative bacteria. J Chemother 1998, 10:17-21.
28. Tredget EE, Shankowsky HA, Rennie R, Burrell RE, Logsetty S. Pseudomonas infections in the thermally injured patients. Burns 2004, 30:3-26. 10.1016/j.burns.2003.08.007, 14693082.
29. Kusuma CM, Kokai-Kun JF. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus. Antimicrob Agents Chemother 2005, 49:3256-3263. 10.1128/AAC.49.8.3256-3263.2005, 1196283, 16048934.
30. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999, 37:1771-1776. 84946, 10325322.